Amended Current Report Filing (8-k/a)
January 03 2022 - 6:32AM
Edgar (US Regulatory)
0000727346
true
0000727346
2021-12-29
2021-12-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A-1
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 29, 2021
SELECTIS
HEALTH, INC.
(Exact Name of Registrant as Specified in its Charter)
Utah
|
|
0-15415
|
|
87-0340206
|
(State
or other jurisdiction
of
incorporation)
|
|
Commission
File Number
|
|
(I.R.S.
Employer
Identification
number)
|
8480
E. Orchard Road, Ste. 4900, Greenwood Village, CO
|
|
80111
|
(Address
of principal executive offices)
|
|
(Zip Code)
|
Registrant’s
telephone number, including area code: (720) 680-0808
(Former
name or former address, if changed since last report)
☐
|
Written
communications pursuant to Rule 425 under the Securities Act
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each Class
|
|
Trading
Symbol
|
|
Name
of each exchange on which registered
|
N/A
|
|
N/A
|
|
N/A
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
ITEM
5.02
|
RESCISSION
OF COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
|
On
December 30, 2021, Selectis Health, Inc., announced the grant of Restricted Stock Units (“RSU”) to certain of its officers.
The RSU’s were issued under the Company’s 2021 Deferred Compensation and Equity Award Plan which was adopted effective July
1, 2021 (the “Plan”).
After
further consideration, the Company and the grantees of such RSU’s, Lance Baller and Randy Barker, have agreed to rescind those
grants.
|
Item
|
|
Title
|
|
|
|
|
|
4.4
|
|
Rescission Agreement
|
|
104
|
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
Selectis
Health, Inc.
|
|
(Registrant)
|
|
|
Dated:
January 03, 2022
|
/s/
Lance Baller
|
|
Lance
Baller, CEO
|
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Apr 2024 to May 2024
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From May 2023 to May 2024